Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content.
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 6 (3) , 279-285
- https://doi.org/10.1007/s10434-999-0279-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryPublished by Elsevier ,2002
- Apoptosis and chemotherapy resistanceEuropean Journal Of Cancer, 1996
- Programmed cell death and radioresistanceCancer and Metastasis Reviews, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology, 1995
- Trends in pancreatic cancer mortality in Europe, 1955–1989International Journal of Cancer, 1994
- Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreasInvestigational New Drugs, 1994
- Pancreatic cancer: the greatest oncological challengeBMJ, 1988
- Rapid colorimetric assay for cell growth and survivalJournal of Immunological Methods, 1986